CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The antiviral response to Tenofovir disoproxil fumarate (TDF) is comparable in Lamivudine (LAM)-naïve and LAM-experienced subjects treated for chronic Hepatitis B (CHB)
DOI 10.1055/s-0028-1089451
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Manns, T Berg, P Buggisch, S Mauss, G Teuber, WO Böcher, J Sorbel, J Anderson, E Mondou, F Rousseau
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: TDF, an obligate chain terminator and a nucleotide analogue, approved for the treatment of HIV-1 also has activity against hepatitis B virus (HBV). Treatment response for a subset of subjects from Studies 102 and 103 previously treated with LAM) was compared to subjects naïve to LAM in these two pivotal studies. Methods: These double-blind studies randomized mono-infected subjects with HBeAg positive (+) or HB…
Zitieren
Zitierempfehlung
M Manns, T Berg, P Buggisch, S Mauss, G Teuber, WO Böcher, J Sorbel, J Anderson, E Mondou, F Rousseau (2008) The antiviral response to Tenofovir disoproxil fumarate (TDF) is comparable in Lamivudine (LAM)-naïve and LAM-experienced subjects treated for chronic Hepatitis B (CHB). Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089451
Mit CareLit weiterarbeiten